There are few complications of bone marrow transplantation more dangerous than a viral infection that heads for the lungs.
Jim Boonyaratanakornkit, MD, PhD, aims to do something about it.
With a team of researchers at Fred Hutchinson Cancer Center, he is reporting progress on the development of an experimental drug combination to prevent infection by four common respiratory viruses. Before the emergence of COVID-19, these four have been blamed for more than half of serious lung infections in patients with compromised immune systems, such as those recovering from transplants.
